Health Care & Life Sciences » Pharmaceuticals | Hubei Jumpcan Pharmaceutical Co. Ltd.

Hubei Jumpcan Pharmaceutical Co. Ltd. A | Mutual Funds

Mutual Funds that own Hubei Jumpcan Pharmaceutical Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Invesco Great Wall Ding Yi Fund
5,125,469
0.63%
538,200
9.01%
12/31/2017
Invesco Great Wall Emerging Growth Fund
4,082,445
0.5%
1,189,676
9.1%
12/31/2017
3,947,708
0.49%
2,335,007
6.73%
12/31/2017
3,315,242
0.41%
1,478,524
3.71%
12/31/2017
2,670,588
0.33%
0
7.82%
12/31/2017
1,600,000
0.2%
1,600,000
4.46%
12/31/2017
Penghua Value Advantage Fund
1,532,800
0.19%
1,532,800
3.51%
12/31/2017
1,485,218
0.18%
1,268,761
5.88%
12/31/2017
China AMC Dividend Fund
1,294,810
0.16%
0
0.66%
12/31/2017
1,200,000
0.15%
1,200,000
0.54%
06/30/2017

About Hubei Jumpcan Pharmaceutical Co.

View Profile
Address
Baota Bay
Taizhou Jiangsu 225441
China
Employees -
Website -
Updated 07/08/2019
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the drug research and development, production, and sale. Its product covers pediatrics, breathing, and digestion field. Its product focuses on anti-inflammatory oral solution, enteric-coated capsules, and children fever particles.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.